According to a metanalysis of case-control studies, the C677T polymorphism in MTHFR is linked to 36–87% higher incidence of hypertension due to reducing catalytic activity by MTHFR enzyme resulting in hyperhomocysteinemia (HHcy) [8]. The gene discussed is MTHFR; the disease is hyperhomocysteinemia.